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AbstrAct
Abdominal aortic aneurysm (AAA) in women is rare; the prevalence is approximately 0.5% 
in elderly women, to compare with 2-4% in aging men. The few women that suffer from AAA 
are older and have a higher rupture risk. A preventive effect of estrogen on AAA formation 
in animal models implies that the lower prevalence of AAA in women can depend on a 
protective effect of female sex hormones. The knowledge is scarce of how the aneurysm wall 
of women differs from that of  men. Altogether, it is likely that biological gender differences 
could influence the risk of AAA development, growth rate and rupture risk. This thesis, based 
on five papers, focuses on risk factors for AAA in women and gender differences in the 
aneurysm wall. 
In the first paper, a case-control study, the reproductive history in women with AAA and a 
control group of women with peripheral artery disease was investigated. 280 women were 
invited to answer a questionnaire about their reproductive history and general health. The 
response rate was 70% and the results showed a lower mean menopausal age in women with 
larger AAA compared with women with smaller AAA and women with peripheral artery 
disease. The second paper, a case-control study, investigated previously reported, potential 
biomarkers for AAA. These had never been analysed in women with AAA and thus it was 
uncertain if they would apply to a female cohort. Men and women were in many aspects 
similar in biomarker profile, with the exception of matrix metalloproteinase 9 (MMP9). The 
levels of MMP9 were higher in women compared with men, with equally large AAA. In 
the third paper elastin content and elastolytic proteins in the aneurysm wall of men and 
women were analysed. 37 patients were included. The results suggest a more pronounced 
elastolysis and a lower elastin content in women compared with men. In the fourth paper 
collagen and its cross-linking were studied in 28 patients with AAA. The results showed no 
difference in the relative collagen content between men and women but a different collagen 
cross-linking in women compared with that in men. The findings might have implications 
for the biomechanical properties of the aneurysm wall in women, yet further analyses are 
required to clarify the mechanisms. The fifth paper was a study of the degree of apoptosis and 
inflammation, in relation to smooth muscle cells in the aneurysm wall of men and women. 40 
patients with AAA were included. The findings suggest a more pronounced apoptosis in the 
aneurysm wall of women compared with men, which might be related to a greater infiltration 
of inflammatory cells. 
In conclusion, women with larger AAA have an altered reproductive history with a lower mean 
menopausal age, suggesting hormonal changes to be of importance for AAA development in 
women. The observed gender differences in the aortic wall described in this thesis, contribute 
to the presently poorly understood  biological and morphological processes that trigger 
aneurysm development, progression and rupture. 

List of scientific pApers
I.	 Reproductive	history	in	women	with	abdominal	aortic	aneurysms
  Villard C, Swedenborg J, Eriksson P, Hultgren R
  J Vasc Surg. 2011 Aug;54(2):341-5
II.		 Biomarkers	for	abdominal	aortic	aneurysms	with	a	gender	
perspective
  Villard C, Wågsäter D, Swedenborg J, Eriksson P, Hultgren R
  Gend Med. 2012 Aug;9(4):259-266
III.	Differences	in	elastin	and	elastolytic	enzymes	between	men	and	
women	with	abdominal	aortic	aneurysm
  Villard C, Eriksson P, Swedenborg J, Hultgren R
  Accepted for publication in AORTA
IV.	 Collagen	cross-linking	in	men	and	women	with	abdominal	aortic	
aneurysm 
  Villard C, Eriksson P, Hanemaaijer R, Lindeman J H, Swedenborg J, Hultgren R
  Manuscript
V. More	apoptosis	in	women	with	abdominal	aortic	aneurysm	
compared	with	men 
  Villard C, Eriksson P, Jorns C, Swedenborg J, Hultgren R, Roy J
Manuscript

popuLärvetenskApLig sAmmAnfAttning
Bråck på stora kroppspulsådern i buken kallas för abdominellt aortaaneurysm (AAA) vilket 
uppstår till följd av att de proteiner som ger kärlväggen dess stadga och elasticitet bryts ned. 
Detta i sin tur leder till att kärlväggen försvagas och därmed vidgas. Allteftersom bråcket 
växer ökar belastningen på kärlväggen och därmed även risken för att bråcket spricker, s.k. 
ruptur. Rupturerat AAA är ett tillstånd som är förenligt med hög dödlighet. Den underliggande 
mekanismen bakom nedbrytningen av kärlväggen och därmed uppkomsten av AAA är 
ännu inte påvisad. Man har emellertid kunnat påvisa att manligt kön utgör en riskfaktor. 
Förekomsten av AAA hos äldre män är 4-6 gånger högre än den för kvinnor i samma 
åldersgrupp. Det finns andra skillnader i utveckling, prognos och behandling mellan de två 
könen såsom att risken för ruptur är högre för kvinnor jämfört med män. Det övergripande 
syftet med denna avhandling var att undersöka kvinnor med AAA; deras riskfaktorprofil och 
hur den aneurysmatiska kärlväggen skiljer sig mellan könen. 
Det första delarbetet kartlade den gynekologiska sjukhistorien hos kvinnor med och utan 
AAA. Resultaten visade att kvinnor med stora AAA har en lägre menopausålder jämfört med 
kvinnor med mindre AAA och kvinnor utan. 
I det andra delarbetet uppmättes nivåer av kärlväggsförsvagande proteiner, som skulle kunna 
utgöra diagnostiska och prognostiska markörer för AAA, i cirkulerande plasma hos kvinnor 
och män med AAA. Resultaten visade att män och kvinnor är i många avseende lika, med 
undantag av en biomarkör. Nivåerna av denna biomarkör var högre hos kvinnor jämfört med 
män, med lika stora aneurysm.  
I det tredje delarbetet undersöktes mängden av elastin, som ger kärlväggen dess elasticitet 
och proteiner som bryter ned det, i aneurysmvägg hos män och kvinnor. Mindre elastin och 
en större mängd kärlväggsnedbrytande protein sågs i kvinnors aneurysmvägg jämfört med 
mäns, vilket tyder på en större nedbrytning av kärlväggen hos kvinnor.
Det fjärde delarbetet syftade till att jämföra mängden kollagen, det protein som ger kärlväggen 
dess styrka, och dess uppbyggnad hos män och kvinnor med AAA. Resultaten kunde inte 
påvisa någon skillnad i kollagenmängd men i dess uppbyggnad mellan könen. Vidare studier 
krävs för att klarlägga mekanismen bakom skillnaden i kollagenets uppbyggnad mellan 
könen och dess beydelse för aneurysmväggens styrka.
I det femte delarbetet undersöktes graden av celldöd,och mängden glatta muskelceller och 
inflammatoriska celler i aneurysmväggen hos män och kvinnor. Resultaten visade på en mer 
uttalad celldöd i kvinnors kärlvägg tillsammans med lägre uttryck av markörer för glatta 
muskelceller och högre uttryck av markörer för inflammatoriska celler. Detta talar för en mer 
uttalad nedbrytning, i form av celldöd, i kvinnors aneurysmvägg jämfört med mäns.  
  
Sammantaget visar studierna att kvinnor med större AAA har en förändrad reproduktiv anamnes 
med en lägre menopausålder, vilket skulle kunna vara av betydelse för aneurysmutveckling 
hos kvinnor. De biologiska och morfologiska processer, som ger upphov till utveckling, 
tillväxt och ruptur av AAA hos män och kvinnor är väsentligen okända. De beskrivna 
analyserna av könsskillnader i aneurysmväggen i denna avhandling, bidrar till att utöka det 
idag begränsade kunskapsläget. 
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List of AbbreviAtions
AAA   Abdominal aortic aneurysm
AP                    alkaline phosphatase
ASI   aortic size index
BAX   BCL2-associated X protein
BMI   body mass index
BSA   body surface area
CD   Cluster of differentiation
CT   computer tomography
CVD   Cardiovascular disease
DM   Diabetes mellitus
ECM   extracellular matrix
ELISA   Enzyme-linked immunoassay
ER   Endoplasmatic reticulum
ERα   Estrogen receptor α
ERβ   Estrogen receptor β
EVAR   Endovascular aneurysm repair
FAS   Fas cell surface death receptor
HP   Hydroxylysyl pyrdinoline
HPLC   High performance liquid chromatography
HRT   Hormone replacement therapy
ICU   Intensive care unit
IFU   Instructions for use
ILT   Intraluminal thrombus
IR   interquartile range
LH   Lysyl hydroxylase
LOX   Lysyl oxidase
LP   Lysyl pyridinoline
MMP   Matrix metalloproteinase
MS4A1                     Membrane-spanning 4 domains subfamily A member 1
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NIH   National Institutes of Health
OR   open repair
PAA   Popliteal artery aneurysm 
PAD   Peripheral artery disease
PCR   Polymerase chain reaction
PVDF   Polyvinylidene fluoride
PLOD   Procollagen-lysine-2-oxoglutarate-5-dioxygenase
PR   Progesterone receptor
p53   Tumor protein p53
RCT   Randomized controlled trial
RPLP0   Ribosomal protein large P0
PCR   Polymerase chain reaction
SD   standard deviation
SHBG   Sex hormone-binding-globulin
TAA   Thoracic aortic aneurysm 
TUNEL        Terminal deoxynucleotidyl transferase mediated 2’-deoxyuridine   
   5’-Triphosphate nick-end labeling     
VSMC   Vascular smooth muscle cell 
WHI   Women’s Health Initiative  
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introduction
Aneurysms	in	history
 “If thou examinest a swelling of vessels in any limb of a man, and thou findest that it 
is hemispherical and grows under thy fingers, at every going (i.e. pulsation) but if it 
is separated from his body, it cannot an account of that become big and not give out 
(diminish), then thou shalt say concerning it: it is a swelling of a vessel. It is vessels that 
cause it and it arises through injury to a vessel. 
   Citation from Ebers Papyrus dated 1550 B.C. 
The Ebers Papyrus is the first document describing aneurysms and their characteristics. 
Surgical treatment was not considered a possible remedy: “Thou shalt not put thy hand on 
any likeness of this” in favour of the prescribed spell: “Flow out, thou vessel that jumps (i.e. 
pulsates)”.(1) 
The treatment for aneurysms has come a long way since the recommended ancient 
spell. The use of synthetic grafts for aortic aneurysms, thoracic and abdominal, was first 
introduced in the 1950s and the minimally invasive endovascular approach, in the 1990s. 
(2-4) They are both today, in refined forms, the surgical treatments considered when treating 
aortic aneurysms.
Definition
An aneurysm is a widening of a blood vessel and it arises as a result of a weakened vessel 
wall. Arterial aneurysms can be classified based on their location, form and etiology. Arterial 
aneurysms can arise at any location but are most prevalent in the infrarenal abdominal aorta.
(5-8) Based on the form of the aneurysm it can be categorised as fusiform or less common, 
saccular.(9) Figure I. For the majority of arterial aneurysms the etiology is unknown. 
Aneurysms with a clear etiology such as congenital, infectious and those related to connective 
tissue disorders are rare.(9-13) This thesis focuses on aneurysms in the abdominal aorta, i.e. 
abdominal aortic aneurysms (AAAs). 
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Figure I. Shape of AAA: a) fusiform and b) saccular.
The abdominal aorta is defined as aneurysmal if its diameter measures at least 1.5 times to 
that of the adjacent or expected normal aortic diameter.(14, 15) In general practice an AAA is 
considered present if the abdominal aortic diameter measures 3.0 cm or more.(16) 
The	aortic	vessel	wall
The aorta is composed of three layers. Tunica intima, which is the innermost layer, faces 
the arterial lumen and is made up of endotelial cells attached to the basal lamina. Tunica 
media, the middle layer, is a network of vascular smooth muscle cells (VSMCs) fenestrated 
by elastic and collagen fibres. Tunica adventitia, the outermost layer, is mainly composed 
of fibroblasts and loose connective tissue. Figure II. The vasa vasorum, the blood supply of 
the vessel wall, nourishes the tunica media and adventitia, whereas the innermost layer is 
provided for by the vessel lumen.(9) 
The aortic wall depend on the biomechanical properties of elastin, collagen and VMSCs to 
withstand the pulsatile arterial blood flow.(17, 18)
Elastin
The elastic fibres provide elasticity to the aortic vessel wall.(17) The elastic fibers form layers 
between VSMCs in the medial layer of the aortic wall. Figure II and Figure III c.(19) The 
principal components of elastic fibres are elastin and microfibrils.(20) Elastin is formed from 
its precursor tropoelastin and is cross-linked by the enzyme lyxyl oxidase (LOX) into an 
amourphorus core, mantled by microfibrils.(20-22) The elastin fibres are composed to impart 
resilience for a lifetime, with limited synthesis in adulthood.(23)
a)	   b)	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Collagen
The strength of the aortic wall can be ascribed to collagen. Figure III a.(17, 24) Collagen 
type I and III are the predominant collagens of the aorta.(25) The biosynthesis of the 
unique molecular structure of collagen is an intricate process with several critical steps of 
modification, to ensure its mechanical stability.(26, 27) The triple helix is the fundamental 
unit of the collagen fibre. It is composed of three polypeptide chains, linked toghether by 
disulfid bonds in the endoplasmatic reticulum (ER).(24) Besides the solid stucture of the 
collagen triple helix, the stability of collagen is dependent on cross-linking, which bind 
adjacent collagen molecules to one another. The collagen cross-linking is inititated in 
the ER by lysyl hydroxylase (LH), also referred to as: procollagen-lysine, 2-oxoglutarate 
5-dioxygenase (PLOD). LH hydroxylates lysine side chains in the polypeptide chain.(28) In 
the extracellular space, triple helices cross-link to one another, partly by LOX and partly by 
self-assembly.(29) The mature collagen cross-linking ultimatelly formed are hydroxylysyl 
pyrdinoline (HP) and lysyl pyridinoline (LP).(30)  
Vascular smooth muscle cells
VSMC is the main celltype of the tunica media. Figure III e. The principal function of mature 
VSMCs is to control vessel tone and diameter through the contractile proteins that they 
express.(31) VSMCs also have an important role in synthetizising and repairing the structural 
elements of the extracellular matrix (ECM), such as elastin and collagen.(32-35) It is the 
Figure II. Aorta and magnification of the three layers of the aortic wall: a) tunica intima, b) 
tunica media and c) tunica adventitia.
Introduction
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remarkable placticity of VSMCs that makes them capable of switching phenotype, from 
contractile to synthetic. By phenotype modification VSMCs can adapt to different stages of 
development and environmental changes.(31)  
Figure III. a) Masson trichome staining of healthy aortic wall and b) aneurysm wall. c) Weigert’s- 
van Gieson’s staining of healthy aortic wall and d) aneurysm wall. e) Staining of smooth muscle 
α-actin in healthy aortic wall and f) aneurysm wall. 
Masson trichome staining: muscle fibres turned red and collagen turn blue. Weigert’s- van Gieson’s 
staining: elastic fibres turn dark purple, muscle turn yellow, nuclei turn brown and connective tissue 
turn red. Smooth muscle α-actin staining: smooth muscle α-actin turn red.
a)	   b)	  
c)	   d)	  
e)	   f)	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Development	of	AAA
Pathogenesis
AAA develops due to a weakening of the aortic wall, resulting in the characteristic dilatation 
and elongation of the aorta. The mechanisms by which aneurysms are initiated are poorly 
understood. Present knowledge suggests inflammation to play a pivotal role, yet it remains 
unknown if the inflammatory process is in fact the triggering event.(36-39) 
The aortic wall is weakened by proteolytic enzymes, which have the capacity to degrade the 
structural elements of the ECM.(40-42) One of the hallmarks of AAA is the fragmentation 
of elastin, causing the initial dilatation in AAA formation.(43) In the absence of elastin the 
strength of the vessel wall resides in collagen, with its ultimate load-bearing capacity.(43, 
44) It is the continued deterioration of collagen and ultimately its failure in sustaining the 
pulsatile pressure, that results in aneurysm rupture.(43) Another important element in AAA 
pathogenesis is the loss of VSMCs, by apoptosis.(45, 46) With the depletion of VSMCs the 
vessel wall loses its principal cell type involved in maintaining vessel wall integrity.(17, 47) 
The proteolytic enzymes involved in aneurysm formation are produced by infiltrating 
inflammatory cells and modified VSMCs, in the tunica media and adventitia.(36, 48, 49) The 
protoelytic enzymes most associated with AAA development are members of the family of 
matrix metalloproteinases (MMP).(50) 
Biomarkers for AAA
The identification of biomarkers for AAA could be of importance both as a diagnostic tool 
to differ healthy from diseased but also to single out AAAs at risk of growth and rupture. All 
molecules involved in the degenerative process are hypothetical candidates in the pursuit of 
finding biomarkers for AAA.(51) There are today, despite numerous studies, no universal 
biomarkers for AAA, illustrating the complexity of the pathogenic processes involved in 
AAA development.(51) 
The intraluminal thrombus
An intraluminal thrombus (ILT) is present in most AAAs.(52, 53) The ILT is a bioactive 
fibrin clot with intercalated hematopoietic cells and inflammatory cells,  and it arises as a 
result of altered blood flow in the dilated aorta.(54) The ILT, was initially perceived as a by-
product of the aneurysm disease, but at present contradictory results are reported regarding 
the effect of the ILT on aneurysm progression.(55) On one hand, the ILT has been shown to 
promote the degradation of the underlying aneurysm wall and thereby contribute to aneurysm 
progression, whereas other studies suggest the ILT to mediate a protective effect on aneurysm 
wall stress.(53, 56-61) 
Introduction
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Risk	factors	for	AAA
Although the pathogenesis of AAA is still unknown there are some important risk factors 
associated with its development and progression:
Age is an important risk factor for both development of AAA and aneurysm rupture risk.(62, 
63) AAA primarily affects an elderly population and is rare beneath 50 years of age.(64) 
Male gender is strongly associated with AAA development, with a male:female prevalence 
ratio of 4-6:1.(63, 64) Wherein the risk of being male lies is not fully understood but it has 
been associated with differences in the endogenous production of sex hormones, anatomy 
and behavioural health in men compared with women.(65, 66) 
Family history of AAA increases the risk of AAA formation. The genetic influence is 
illustrated by the higher prevalence in siblings to patients with AAA compared with that in 
the general population.(67, 68) In a first-degree relative to a patient with AAA, the relative 
risk of developing an AAA is approximately doubled compared with that in the general 
population.(68) 
Smoking is an important risk factor for AAA and is the only modifiable one.(7, 69) Besides 
being linked to its formation, smoking has been shown to increase the growth and rupture 
rate of AAAs.(62) The mechanism by which smoking promote AAA formation is not fully 
understood but animal models suggest an effect of nicotine on elastin degradation, expressions 
of MMPs and inflammatory activity.(70-72) 
Hypertension and cardiovascular disease are strongly associated with AAA.(7, 64) 
Atherosclerotic disease, i.e. cerebrovascular, coronary artery and peripheral artery disease 
(PAD) have all been observed in a greater extent in patients with AAA.(7) On the other hand, 
diabetes mellitus (DM), another important risk factor for atherosclerotic disease, has been 
negatively associated with AAA occurrence.(7, 73)
Gender	aspects	on	presentation	and	progression	of	AAA
Prevalence and screening 
AAA predominantly affects an elderly male population.(63) When using the threshold of 3.0 
cm for defining an AAA, the prevalence in an elderly Swedish population is approximately 
0.5% in women and 2% in men.(74, 75) Men are recommended screening for AAA at the age 
of 65 years, according to several guidelines.(76) The screening recommendations for women 
are more controversial.(76) Some guidelines do not recommend screening in women, probably 
due to the low prevalence rate and the late development of disease, which limit the number 
of preventable deaths with a screening a programme.(77, 78) Other guidelines however, do 
recommend screening of women with risk factors, such as smoking, cardiovascular disease 
(CVD) and familial history of AAA.(79, 80) 
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Anatomy and aneurysm wall strength 
The diameter of the aorta correlates with height, weight and body surface area (BSA). Women 
are in general smaller than men and consequently they have smaller vessels.(81, 82) The 
proportionally smaller aortas in women have implications for aneurysm progression. Because 
women’s aortas are smaller than men’s, the relative enlargement of women’s AAA exceed 
that of men’s, at any given diameter.(83, 84) Aortic size index (ASI) is a measurement, which 
takes the relative enlargement into account. It has shown to be a determinant for rupture risk 
in women.(85) Thereto, women have smaller aneurysm neck diameter, shorter neck length, 
increased neck angulation and smaller iliac arteries.(81, 86) These anatomical components 
are all of importance for the choice of surgical treatment.(81)
In finite element models, aimed to assess aneurysm wall strength, women have been reported 
to have a lower aneurysm wall strength compared with men.(87, 88) The lower wall strength 
in women has been associated with the increased rupture risk in women and as suggested, 
could be related to differences in biomechanical properties in the aneurysm wall between 
men and women.(87, 88) 
Risk factor - smoking
The decline of male smoking is believed to have contributed to the decline in AAA prevalence 
observed in the 21th century, yet smoking trends differ in women.(89, 90) The incidence of 
smoking in women is increasing in several countries and fewer women than men quit smoking.
(90-92) Thereto the effects of smoking in women may be more detrimental, illustrated by the 
higher risk for AAA in smoking women compared with smoking men.(69, 93, 94) 
Growth rate
The aneurysm growth rate varies widely in different reports (1 mm /year - 8 mm/year).(95, 
96) A mean aneurysm growth rate of 2.2 mm/year, independent of gender, was reported in a 
recent meta-analysis.(62) 
Different factors have been shown to influence aneurysm growth rate, such as aneurysm size, 
smoking and more controversial, intraluminal thrombus and female sex (62, 97-100). A few 
studies have reported a greater expansion rate in women.(97, 101) 
Rupture risk
A higher proportion of women with AAA presents with rupture, 21% of women to compare 
with 16% of men.(102) Women with AAA have a fourfold risk of rupture compared to 
men and it occurs much earlier in the course of the disease.(62, 95) The average diameter 
preceding rupture is 6.0 cm in men while it is 5.0 cm in women.(95) Potential explanations 
are, as mentioned above, a greater relative aneurysm enlargement in women and/or a reduced 
wall strength in the aneurysm wall of women.(83, 87, 88) 
Introduction
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Concurrent aneurysms
A higher proportion of women have concurrent thoracic aortic aneurysms (TAAs) but rarely 
femoral and popliteal artery aneurysms (PAAs), which are almost exclusively observed in 
men. (103, 104)
Biomarkers
An ideal biomarker is involved in a pathogenic pathway prevalent in all affected patients. 
The difference in prevalence and progression of AAA in women suggest that the pathogenic 
pathways might differ in some aspects between the sexes.(7, 62) Despite these observed 
gender differences, the studies performed on potential biomarkers for AAA are all primarily 
based on male cohorts.(51, 62) Biomarkers for AAA in women have not been studied. 
Gender	differences	in	treatment	of	AAA
Intact AAA
The medical treatment prescribed to patients with AAA is similar to other patients with 
cardiovascular risk factors, i.e. antiplatelet treatment and statins.(16, 79) The current 
guidelines recommend surgical treatment in men at an aneurysm diameter of 5.5 cm.(16, 79) 
For women the threshold is set lower since they, due to their increased rupture rate, might 
benefit from early repair, i.e. at an aneurysm diameter of 5.0 - 5.4 cm.(16, 79) The extent of 
secondary prevention, prescription of aspirin and statins, has been shown inadequate for both 
men and women, yet more pronounced in women. Women are less likely to be prescribed 
aspirin as secondary prevention, compared with men.(105)
Two vascular interventions are presently used to prevent sudden death from aneurysm 
rupture in patients with AAA; open repair (OR) and Endovascular aneurysm repair (EVAR). 
EVAR is a less invasive treatment, enabling treatment without the risks associated with 
open surgery. However, it cannot be used in all patients due to aneurysm morphology.(106-
110) An increasing number of patients with AAA are treated with EVAR rather than OR, 
but this trend is predominantly found in men.(102, 111, 112) One potential explanation for 
the lower number of women receiving EVAR might be a less favourable morphology. The 
smaller diameter of the aneurysm neck, shorter aneurysm neck length, increased aneurysm 
neck angulation and smaller iliac arteries in women most likely contribute to fewer women 
meeting the Instructions for Use (IFU) criterions for the devices used in EVAR.(81) It was 
recently reported that only 12% of women receiving EVAR meet the criterions for length, 
diameter and angulation of the aneurysm neck.(81) Thereto, women are more often treated 
outside IFU criterions.(113) 
25
Outcome after surgery of intact AAA
Several randomized controlled trials (RCT) have been performed in order to identify the 
optimal treatment alternative for patients with AAA.(106-110) The limited amount of women 
in these trials makes it difficult to generalize the findings of these RCTs to female patients. 
In registry studies including women, a worse outcome after surgery have been reported in 
women compared with men, regardless of surgical treatment.(102, 114)
Women treated electively with EVAR suffer higher 30-day mortality and more postoperative 
complications compared with men.(114, 115) The more complex vascular anatomy in 
women render them less favourable for EVAR and may contribute to the greater occurrence 
of procedural-related complications.(111) Women treated with EVAR have an estimated four 
times higher rate of complications compared with men.(116)
Women treated electively with OR suffer higher 30-day mortality, more postoperative-
complications and have a worse long-term outcome.(114, 117) Women suffer from cardiac 
and pulmonary complications as well as renal failure to a greater extent compared with men, 
leading to longer stays in the Intensive care unit (ICU).(111, 117) Proposed explanations 
to the worse outcome and greater degree of complications in women are their older age at 
treatment and more comorbid conditions.(111) 
Ruptured AAA
Women who present with rupture are older than men.(118, 119) Women’s AAA rupture at 
smaller diameter and more women present with aneurysm rupture compared with men, yet 
women are less likely to be admitted to hospital and receive treatment.(102, 111, 120, 121) 
Outcome after surgery of ruptured AAA
Even though outcome results for women treated for ruptured AAA have varied the majority 
have reported women to fare worse.(102, 118-120, 122) Women with AAA are more likely to 
die from their ruptured AAA, as illustrated by the higher 30-days case fatality rate in women 
compared with men.(102, 118, 122) 
The	effect	of	gender	on	aneurysm	formation	
The gender differences observed in CVD, being more prevalent in men than in women and 
with an increasing incidence in women after menopause, point towards an effect of sex 
and sex hormones on CVD pathogenesis.(123, 124) Estrogen has been shown to have an 
antiatherogenic effect, which is mediated both directly and through the actions of the estrogen 
receptors, estrogen receptor α (ER α) and estrogen receptor β (ER β).(125) However, the 
antiatherogenic effects of exogenous estrogen and progesterone are not universal, as has been 
illustrated by the adverse events observed in the Women’s Health Initiative (WHI) trials. 
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Women in the treatment group, receiving hormone therapy, suffered more cardiovascular 
events compared with the placebo group.(126) 
A similar pattern of gender disparity is observed in AAA, predominantly affecting men and 
developing later in women, which suggest gender to be of importance for AAA formation. 
The effect of gender on AAA development has been demonstrated in several animal models. 
In the beginning of the 21 century, estradiol treatment was reported to limit aneurysm 
development in an angiotensin-II-induced aneurysm model on apolipoprotein E-deficient 
mice.(127) In an elastase perfusion model, male rats developed larger AAA than females, 
associated with increased macrophage infiltration and higher levels of MMP-9. It was also 
shown that female rat aortas, when transplanted into males, became more susceptible to 
aneurysm development.(128) A protective effect of estrogen was further illustrated by the 
observed increased growth rate of AAA in ovariectomized female rats, compared with sham-
operated females and male rats that received estradiol pellets. The growth rate was associated 
with increased levels of MMP-2 and -9.(129) The protective effect of estrogen was in female 
mice associated with an increased protein and mRNA expression of ERα compared with 
males.(130)
An effect of androgens on AAA development was observed in an angiotensin-II-induced 
aneurysm model on apolipoprotein E-deficient mice, where orchiectomy was shown to 
decrease aneurysm growth.(131, 132) In an attempt to elucidate the effect of both androgens 
and estrogens on aneurysm formation, rats were orchidectomized and oophorectomized. As 
a result, lower aneurysm growth rates were observed in orchidectomized males compared to 
male controls, whereas oophorectomy did not affect growth rates in females.(133) However, 
in the same study oophorectomized female rats given estrogen exhibited decreased aneurysm 
growth, which was instead increased in male rats that underwent orchiectomy and received 
testosterone pellets.(133) Most animal models illustrate a preventive effect of estrogen on 
aneurysm formation by inhibiting the production of proteolytic enzymes involved in the 
degradation of the ECM. The role of androgens has been less investigated and consequently 
its potential role in AAA formation is less elucidated.
The scarce numbers of studies focused on the potential effect of sex hormones on AAA 
development in men and women are not without discrepancy. In women, the association 
between HRT and aneurysm occurrence is controversial.(73, 134, 135) A negative association 
between AAA occurrence and hormone therapy for more than five years in women has been 
observed.(73) Although, two other studies, partly looking at the same study population as the 
latter study found no association between HRT and even more AAA events in women with 
AAA than controls, respectively.(135, 136) 
In men, lower levels of testosterone have been associated with AAA.(137) Noteworthy, 
elderly men without AAA have higher levels of circulating estradiol compared with women 
in the same age. As opposed to women, in whom the production of estrogen ceases in 
menopause, the levels in men do not decrease with age due to peripheral aromatization and 
continued synthesis in the testicles.(138, 139) 
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Aims of the thesis
The overall aim of this thesis was to study women with AAA
The specific aims were: 
STUDY I.			 To evaluate the reproductive history in women with AAA in comparison to 
women with an expected similar risk factor profile and secondary to study if 
women with larger AAA differ in their reproductive history from women with 
smaller AAA.
STUDY II.		 To investigate if potential biomarkers for AAAs differ between men and 
women with equally large AAAs and to compare biomarker levels in women 
and without AAA. 
STUDY III.		To compare elastin content and some of the elastolytic enzymes mostly 
associated with AAA development, between men and women with equally 
large AAA. 
STUDY IV.	 To study collagen and collagen cross-linking in the aneurysm wall of men and 
women with AAA.
STUDY V.		 To investigate the degree of apoptosis and inflammation, in relation to VSMC 
content in the aneurysm wall of men and women. 
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pAtients And methods
Study	cohort
Study I. Female patients treated for AAA or PAD consecutively monitored at the Department 
of Vascular Surgery at Karolinska University Hospital, between 2007 and 2010 were included. 
The choice of control group, women with PAD, was based on their expected similar risk 
factor profile for atherosclerotic disease.(7, 140) An a priori power analysis was performed 
to detect the minimum number of participants required to detect a significant difference of 2 
years in menopausal age, at a power of 80%. An additional number of patients were added, 
based on the assumption of a missing case frequency of at least 40%, resulting in a number 
of 140 patients in each group. 
Study II. Women treated for AAA and women consecutively controlled for AAA at the 
outpatient clinic during the time period January 2009 to October 2011, were invited to 
participate. The participating men were included prior to their elective aneurysm repair. A 
control group of age-matched women with PAD, consecutively controlled for their condition 
at the outpatient clinic during the same time period, was also included. The threshold for large 
AAA was set at 5.5 cm, in accordance with practice guidelines for considering treatment.
(79) This rendered 4 groups; women with PAD (n=18), women with AAA < 5.5 cm (n=16), 
women with AAA > 5.5 cm (n=20) and men with AAA > 5.5 cm (n=18).
Plasma samples were collected from the participating women at a scheduled appointment. 
The aneurysm diameter of the patients with AAA ≥ 5.5 cm had been measured by computer 
tomography (CT), within the last 6 months. The aortic diameter of patients with AAA < 5.5 
cm had been measured with either ultrasound or CT no later than 12 months earlier.  The age-
matched control group of women with PAD underwent an ultrasound examination, where the 
maximal aortic antero-posterior diameter was measured. Aortic diameter above or equal to 
2.7 cm was considered aneurysmal.(141) Data from patients’ hospital charts were extracted 
regarding risk factors and comorbid conditions.
Study III-V. In 2008, the Department of Vascular Surgery, Karolinska University Hospital, 
initiated a bio bank of tissue obtained during elective OR. By late February 2012 the number 
of women amounted to 14 and in June 2014 to 19. All treated women were included together 
with male patients chosen to match the age and aneurysm diameter of the participating 
women.
The biopsies were obtained from the ventral infrarenal aneurysm wall, often in midline and 
at the maximum diameter. If possible, two biopsies were taken from each patient, thrombus 
covered and non-thrombus covered aneurysm wall.  The thrombus was removed and stored 
separately. The samples were stored at -80°C until further preparation. Patient characteristics 
were obtained from hospital charts. 
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Questionnaire
To access information of the general health and the reproductive history of the participating 
women in Study I, a validated questionnaire was used.(142) The self-completion questionnaires, 
including 45 questions, were delivered and returned through post. The reliability of the 
questionnaire was confirmed by comparing 20% of the answered questionnaires, about 
general health, to data from the women’s hospital charts. The validity of the questionnaire 
had been established by its use in a prior study of reproductive history in women with lower 
limb ischemia in 2004.(142) 
Laboratory	procedures
ELISA. For the detection and quantification of biomarkers in plasma samples Enzyme-linked 
immunoassay (ELISA) was used. ELISA is a method based on the concept of a stationary 
antibody onto which a sample of unidentified amounts of target antigen is added, i.e. a pre-
coated microplate. A secondary antibody, targeting the antigen, is then added followed by a 
substrate solution. As these components react colour is formed, which can be measured with 
a spectrophotometer.(143) ELISA was used in Study II.
Immunohistochemistry. To detect proteins and identify their location in the aneurysmal wall 
immunohistochemistry was performed. Immunohistochemistry is a technique used to detect 
proteins in a section. A primary antibody, designed to attach to a specific antigen in the tissue, 
is added to the tissue section. The section is then incubated with a biotin-free combination 
of a probe and polymer, which detect the primary antibody and probe, respectively. The 
polymer is labelled with alkaline phosphatase (AP). The probe and polymer form a complex 
that when adding chromogen, give rise to a red colour signal. The signal is the result of a 
reaction between the chromogen and the AP of the probe-polymer complex.(144-146)
Terminal deoxynucleotidyl transferase mediated 2’-deoxyuridine 5’-Triphosphate nick-end 
labeling (TUNEL) staining detects apoptotic cell death in tissues. The technique is designed 
to identify the oligonucleosome fragments in the apoptotic, disintegrated nucleus.(147) 
Terminal doexynucleotidyl transferase catalyses the polymerization of free 3’-OH DNA ends 
and labelled nucleotides. The complex can be visualised using the AP-labelled conjugate and 
chromogen described above.(148) 
Enzyme labels for immunohistochemistry was used in Study III-V. All sections were paraffin 
embedded and prepared by vacuum steaming. TUNEL staining was used in Study V. The 
sections were pre-treated with Proteinase K. The investigator was blinded for sex when 
valuing the staining, using ImageJ analysis software, National Institutes of Health (NIH). 
mRNA expression analysis. Real-time quantitative reverse transcription polymerase chain 
reaction (PCR) was used to quantify the expression of mRNA in the non-thrombus and 
thrombus covered mediae of the aneurysm wall of men and women. The principle of the 
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technique is to firstly convert RNA to a DNA by reverse transcriptase and secondly to amplify 
a precise DNA fragment and quantify its expression. The amplification is regulated by 
temperature and is a result of repeated cycles of DNA denaturation, annealing and synthesis 
of DNA strands. Fluorescent markers bind to the DNA-strands and when they are degraded in 
the DNA synthesis they omit a signal. The omitted fluorescent signaling can be summarised 
and thereby quantified. In quantification, the emissions of the samples are compared to a 
threshold value, set at a given cycle, called the threshold cycle (C
t
) of the amplification. 
For normalization the C
t
 value for the gene of interest is compared to the C
t
 value of a 
housekeeping gene that is expressed at a constant level.(149) 
mRNA expression analysis by real-time reverse transcription PCR was used in Study III-V. 
The housekeeping gene Ribosomal Protein Large P0 (RPLP0) was used for normalization 
and samples were run in duplicates.
Western blot. Western blot analysis was used to quantify protein expression in the thrombus 
and non-thrombus covered media of the aneurysms. Western blotting is a technique used for 
detection and analysis of individual proteins. Tissue samples are prepared by protein extraction 
and the proteins are separated from one another by gel electrophoresis. By electroblotting the 
separated proteins are transferred to a membrane of polyvinylidene fluoride (PVDF). Un-
specific binding of antibodies to the surface of the membrane is prevented by incubation 
with a buffer and protein mixture. Thereafter, the membrane is incubated overnight, with an 
enzyme-labelled antibody, i.e. the primary antibody. The primary antibody complex binds to 
the transfected protein of interest. A secondary antibody, binding to the first antibody, is then 
added before the membrane is incubated with a chemiluminescent substrate. Together they 
form light as an end product. The light product can be captured on a film or with the use of a 
CCD camera. The intensity of the signal correlates with the abundance of the antigen on the 
blotting membrane.(150) 
Western blot analysis was performed in Study III-V. Tris 4-12% SDS-PAGE gels were used 
and densitometry was performed to value the protein expressions. 
High performance liquid chromatography. High performance liquid chromatography (HPLC) 
was used for quantification of collagen and its cross-linking compounds in the thrombus 
covered aneurysm wall of men and women. HPLC is a separation technique where the 
amount of the separated compounds ultimately can be measured.(30) The sample of interest 
is injected with a liquid of water and organic solvent, mobile phase, into a tube packed with 
small porous non-polar particles, called the stationary phase. High pressure, administered 
by a pump, forces the liquid of the mobile phase including the sample of interest through 
the stationary phase. The packing of the stationary phase and the chemical and physical 
interactions, occurring between the molecules of the sample and stationary phase separate 
the compounds from one another. These separated components are detected at the exit of the 
tube by a fluorescence detector connected to a computer, that measures their amount. The 
separation mode using water and organic solvent as liquid phase and non-polar particles in 
the stationary phase is called reverse-phased HPLC. 
HPLC was used in Study IV and the analysis was performed in Leiden, Netherlands.
Patients and  methods
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Statistical	analysis	
The independent sample t-test was applied for comparisons between groups with normally 
distributed, continuous variables and Mann-Whitney or Kruskal-Wallis test were applied for 
comparisons between groups where the data that did not fulfil the assumption of normality. 
Differences for categorical variables were assessed with χ2 test and Fischer’s exact test. 
Differences were considered significant at the level <.05. SPSS software 20 and 21 was used 
for the statistical analysis. 
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resuLts And discussion
Reproductive	history	in	women	with	AAA
The difference in prevalence rate and later development of disease in women suggest gender 
and sex hormones to be of importance for AAA development.(7, 63)
The main result of Study I was the two years lower mean menopausal age in women with 
large aneurysms compared with women with PAD and women with small AAA. Table I. 
As a result, the duration of endogenous production of female sex hormones (years between 
menarche and menopause) was lower in women with AAA ≥5.0 cm than in women with 
AAA <5.0 cm or PAD. Table I. There were no differences between the groups in relation 
to the use of contraceptives, parity, HRT, prior gynecological surgery or breast cancer. 
Regarding risk factor for AAA, i.e. hypertension, hyperlipidemia, heredity for AAA and CVD, 
the two groups of women were in many aspects similar, with one exception. Angina pectoris, 
one of many manifestations of CVD differed between women with AAA and women with 
PAD. The occurrence of angina pectoris was greater in women with AAA compared with 
women with PAD, 26% vs.11%, P=.026. These results are in accordance with the prior studies 
on risk factors for AAA in both men and women.(7) DM has been negatively associated with 
AAA in women.(73) The results of this study are in accordance with these observations, 
illustrated by the lower occurrence of DM in women with AAA compared with women with 
PAD, 15% vs. 28%, P=.034.
Table	I.	Reproductive history in women with PAD, AAA < 5.0cm or AAA ≥ 5.0cm.
PAD
N=98
AAA<5.0cm
n=44
AAA≥ 5.0cm
n=54 P-value
Menarcheal age (range) 13,5 (10-17) 13,5 (10-16) 13,8 (11-18) .597
Menopausal age (range) 49,7 (31-67) 49,9 (30-57) 47,7 (39-64) .011
Duration of endogenous 
hormone production (range) 36,7 (19-54) 36,4 (20-45) 33,9 (24-49) .003
Data presented as mean (range). Significance calculated with Independent t-test.
Smoking has been shown more deleterious to AAA formation in women compared with men, 
in that sense that there is a higher risk of AAA development in smoking women.(69, 93) In 
this study women with AAA were previous or current smokers to a greater extent than women 
with PAD: previous smokers, 52% vs. 46% and current smokers, 46% vs. 34%, P= .001. 
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One way by which smoking affects women is by reducing the menopausal age.(151) The 
mean age for when women in Sweden reach natural menopause is at 51 years of age.(152) 
Smoking reduces the menopausal age by approximately 1.44 years, possibly by affecting 
ovarian function and thereby lowering estrogen levels.(151, 153, 154) Other factors known 
to influence menopausal age are: BMI, parity and menarcheal age.(154) A menopausal age 
of approximately 49.8 years in both women with PAD and women with smaller AAA, as 
observed in this study, is similar to the observed menopausal age of female smokers in 
Sweden.(154) The smoking habits in women with larger and smaller AAA were similar, as 
were BMI, parity and menarcheal age. Consequently, the observed lower menopausal age 
in women with larger AAA could not, in this study, be associated with any of the known 
determinants for menopausal age. 
The effect of female sex hormones on AAA development has been illustrated most distinctly 
in animal models, by an inhibiting effect of estrogen on the protoelytic enzymes involved 
in AAA pathogenesis.(128, 133) The mechanisms observed in animal models have their 
limitations. There are apparent difficulties in mimicking a multifactorial and complex disease, 
such as AAA, in an animal model. In order to value the potential effect of gender on AAA 
development in humans, studies on how hormonal changes in men and women are related to 
AAA occurrence are an important complement to the mechanisms studied in animal models.
Hypothetically, the susceptibility of aneurysm formation in women might be associated 
with an altered hormone profile as has been observed for CVD. Women with early artificial 
menopause and thereby lower menopausal age have an increased risk for CVD, compared 
with women with natural menopause.(155, 156)
If a lower menopausal age influences AAA formation one could hypothetically argue for 
hormone therapy to postpone menopause and thereby prevent AAA development. However, 
based on the results of the WHI trials, where postponing menopause with hormone therapy 
failed to prevent coronary heart disease and potentially even increased its risk, prescribing 
hormone therapy to women in order to prevent AAA would not be safe.(157)
In conclusion, women with larger AAA reach menopause earlier than women with smaller 
AAA and women PAD and this could influence an earlier onset of aneurysmatic disease or 
an increase in aneurysm growth. 
Methodological considerations
One of the strengths of a self-completion questionnaire with several closed-ended questions 
is the exclusion of interviewer bias. A weakness on the other hand is an assumption of literacy 
and comprehension of the Swedish language. Another limitation is the potential of recall 
bias, since several years had passed since some of the events asked about took place, but it 
is unlikely that such a recall bias would influence the groups differently. The questionnaire 
had been validated and its reliability confirmed by an earlier study and by comparing the 
provided data to the patients’ hospital charts.(142) In retrospect the use of a pre-testing and 
conformational interviews could have improved the study.(142) 
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The distinction of large and small aneurysms at 5.0 cm could be questioned but was chosen 
since 5.0 cm is the recommended diameter, according to current guidelines, for considering 
treatment in women.(79) 
Biomarkers	for	AAA	in	women
The lack of studies on biomarker for AAA in women initiated this study.(51) Study II is the 
first one to describe biomarker levels for AAA in women. The results showed, in many aspects, 
similar biomarker profiles in men and women, with the exception of MMP-9. Women with 
AAAs ≥ 5.5 cm had higher levels of MMP-9 compared with men with AAAs ≥ 5.5 cm, 43 
ηg/ml vs. 36 ηg/ml, P=.036. Figure IV. On the other hand, women with larger AAA ≥ 5.5 cm 
had lower levels of MMP-9 compared with women with AAA < 5.5 cm and women with no 
AAA, 43 ηg/ml vs. 117 ηg/mL vs. 133 ηg/mL, P =.003. Figure IV. MMP-9 is the biomarker 
most associated with AAA and has been implicated in AAA formation, growth and rupture.
(158-160) The finding of lower levels of MMP-9 in women with larger AAA compared with 
women with smaller AAA and women without AAA could theoretically be explained by a 
lower production or a greater consumption in the aneurysm wall of women. In either way the 
difference in MMP-9 concentration suggests that the pathogenic pathway involving MMP-9 
differs in men and women with AAA.
Figure IV. Circulating levels of MMP-9 in women with PAD, AAA<5.5cm and women with AAA≥5.5cm.
Prior studies on biomarkers for AAA present different results.(51) It might be related to the 
difficulty in identifying a biomarker for such a complex disease as AAA but it might also be 
related to the inconsistencies in used methodology. It is hard to interpret the results of studies, 
which use different media, forms of proteins, controls and aneurysm size.(159, 161-164) 
Results and discussion
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The results of animal models illustrating a protective effect of estrogen on aneurysm formation 
could, if applied to men and women, suggest a reduced female sex hormone production to be 
contributing to AAA pathogenesis.(128, 129) In Study II, it was evaluated by measurements 
of estrogen levels in women with and without AAA, as well as in men with AAA. The results 
showed higher levels of estradiol in men with AAAs ≥ 5.5 cm compared with women with 
AAAs ≥ 5.5 cm, 87 ρmol/l vs. 30 ρmol/l, P<.001. The observed lower level of estradiol in 
women compared with men is consistent with prior studies.(138, 139) The higher levels of 
estradiol in men compared with women and the similar levels in women with and without 
AAA render estradiol a less suitable biomarker for AAA in women. If estrogen has a protective 
effect on aneurysm formation and the development of AAA in women is in fact related to its 
loss, can be neither confirmed nor denied with this one-time analysis of estradiol. 
In conclusion, the higher levels of MMP-9 in women compared with men suggest that MMP-
9 could be a biomarker related to sex differences in AAA development. The lower levels 
of estradiol in women with AAA compared with men suggest that the possible protective 
effect of endogenous estrogen cannot be explained by a difference in circulating levels of 
estradiol between the sexes. The results illustrate the need for further in-depth analyses of 
true biological sex differences in AAA patients.  
Methodological considerations
The study included a control cohort of patients with PAD. It excluded the potential confounding 
factor of elevated levels as a result of occlusive disease, yet with a group of healthy controls 
even more information could have been obtained. Another group of patients, men with smaller 
AAA, could have further strengthened the study. Retrospectively, the choice of some of the 
biomarkers used in this study can be questioned.(158, 165) The study could have benefited 
from the analysis of additional sex hormones, for instance: testosterone, estrone and sex 
hormone-binding-globulin (SHBG), thereby providing a more complete hormone profile of 
the participating men and women.
The distinction of large and small aneurysms, which was set at 5.5 cm, was chosen based on 
the treatment recommendations for men with AAA.(79) We do recognise that the threshold 
for recommending treatment to women is lower, yet in order to avoid making comparisons 
between different sized aneurysms the threshold diameter was set based on the treatment 
recommendations for men.(79) 
Elastin	and	elastolysis	in	the	aneurysm	wall
The loss of elastin is one of the hallmarks of AAA development.(18) There is scarce 
knowledge of the elastolytic process and elastin degradation in the aneurysm wall of women, 
which might be of importance for the observed gender differences in aneurysm progression. 
(97, 166, 167)
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In Study III, a lower protein expression of elastin in women compared with men, in the 
non-thrombus covered aneurysm wall, was observed. Figure V. There was no difference in 
mRNA expression of elastin between men and women. Table II. We found no difference in 
the expression of MMP-9 between men and women in the thrombus covered aneurysm wall.
The amount of elastin in the aneurysm wall of men and women have been studied recently, 
by Tong et al, reporting a greater dry weight of elastin in women than in men in the thrombus 
covered aneurysm wall.(167) The contradicting findings in this study might be related to 
the use of different methods or differences in patient demographics, i.e. smoking habits, age 
and aortic diameter between the participating men and women.(167) The men were older in 
our study and thoroughly matched to the participating women in relation to age, aneurysm 
diameter and smoking habits.
Table	II.	Gene expression analysis of elastin, MMP-2, -9 and cathepsin K in the non-
thrombus covered aneurysmal wall of men and women.
             Non-thrombus covered wall
P-value
Men with AAA Women with AAA
elastin 4.55 ± 3.21 5.01 ± 3.31 .722
MMP-2 1.52 ± 1.22 1.74 ± 1.51 .744
MMP-9 -.83 ± 1.08 .90 ± 2.59 .041
cathepsin K 1.68  ± 1.06 2.63 ± 1.01 .063
Values presented as mean±SD for normally distributed data. Significance calculated by Independent 
t-test. Values presented log2-transformed and as arbitrary units. MMP- matrix metalloproteinase.
MMP-2 and -9 are the proteolytic enzymes most associated with AAA.(42, 49, 160, 168, 
169) MMP-2 has primarily been associated with early aneurysm formation whereas MMP-9 
has been related to later stages of aneurysm disease.(36) MMP-2 and -9 have both elastolytic 
and collagenolytic qualities.(170, 171) We found higher mRNA and protein expressions of 
MMP-9 in women compared with men, in the non-thrombus covered aneurysm wall. Table 
II and Figure V. There were no differences in mRNA expressions of MMP-2 and cathepsin K 
between men and women. Table II. There were neither differences in the mRNA expressions 
of elastin, MMP-2, -9 and cathepsin K between prior and current smokers, nor between 
smoking and non-smoking men and women.
The differences in elastin and elastolytic enzymes were observed in the non-thrombus covered 
aneurysm wall, as opposed to the thrombus covered wall. The impact of a difference in the 
non-thrombus covered aneurysm wall as opposed to the more prevalent thrombus covered 
aneurysm wall is unknown and requires further studies. 
Based on a report from two decades ago, the degradation of elastin leads to moderate dilatation. 
(18) Theoretically, if applied to the results of this study, it could suggest the lower elastin 
content in women to have implications on aneurysm enlargement. The observed similar ASI 
between men and women in this study suggest that the lower expression of elastin and higher 
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expression of MMP-9 cannot be explained by proportionally larger AAAs in women. It rather 
points towards inherent differences in the aneurysm wall between the sexes. The studies on a 
potential effect of sex hormones on the composition of elastin in the vasculature are scarce. 
Two of these in number few studies, have suggested an impact of female sex hormones 
on elastin composition. One study reported that female sex hormones increase the elastin 
deposition of human aortic VSMCs and another that gender could be of importance for the 
observed greater aortic stiffness in elderly men compared with elderly women.(173, 174) 
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Figure V. Weigert’s-van Gieson’s staining of elastin in the non-thrombus covered aneurysm wall 
of two men. b) Weigert’s-van Gieson’s staining of elastin in the non-thrombus covered aneurysm 
wall of two women. c) Western blot of and densitometry of elastin in the non-thrombus covered 
aneurysm wall of three women and two men, .81 vs. 2.30, P=.200. d) Western blot and densitometry 
of MMP-9 in the non-thrombus covered aneurysm wall of three women and two men, .65 vs. .22, 
P=.200.
39
In conclusion, a greater expression of MMP-9 in the non-thrombus covered aneurysm wall 
in women with a concurrent lower expression if elastin suggest that the proteolytic process 
differs in women in that part of the aneurysm wall. A weaker non-thrombus covered aneurysm 
wall in women, as a result of greater elastolysis could be of importance for the enlargement 
of AAA in women. 
Methodological considerations
All aneurysm tissue in Study III-V was obtained from patients treated electively with OR 
for AAA and consequently the results illustrate an end-stage disease. Little can therefore 
be said of the potential gender differences in earlier stages of disease. Information of the 
earlier stages of aneurysm disease would be even more valuable from a gender perspective 
and have clinical implications. The reducing number of OR, in favour of EVAR, limits the 
number of attainable biopsies. Nevertheless, the sample sizes of Study III-V are consistent 
with prior studies within the research field.(172, 175) 
An ILT is present in almost all larger AAAs.(53) One could argue that an ILT is present 
in all larger aneurysms, although thin, thereby eliminating the concept of non-thrombus 
covered aneurysm wall.
Collagen	and	its	cross-linking in	the	aneurysm	wall 
The greater aneurysm rupture risk observed in women makes the biosynthesis of the load-
bearing collagen of special interest to study from a gender perspective.(62, 95) 
In Study IV, we found the relative collagen content in the aneurysm media, assed by HPLC 
and depicted as Hyp/Pro ratio, to be similar in men and women. Figure VI. Thereto, the 
mRNA expressions of the procollagens: collagen1α1, collagen1α2 and collagen3α1, were 
similar in men and women with AAA. Table III.
Collagen cross-linking is essential for its stability. An impaired collagen cross-linking affects 
its role in maintaining vascular integrity, as observed in human and animal models with 
defective collagen cross-linking.(30, 176-178) HP/LP ratio is an estimate of the stability 
of collagen tissue. The greater the ratio the greater is the stability.(30, 179) The results of 
collagen cross-linking analysis showed no difference in HP per triple helix, .58 vs. .46, 
P=.139 and higher LP per triple helix in women, .14 vs. .07, P=.005. As a result, the HP/LP 
ratio was lower in women, 3.28 vs. 8.41, P=.003. Figure VII. 
Two of the essential enzymatic steps, in the formation of stable collagen, are the hydroxylation 
of lysine residues by PLOD and the formation of reactive aldehydes by LOX.(30) However, 
we found no difference in expressions of PLOD1-2 and LOX to associate with the observed 
gender difference in HP/LP ratio, data not shown.
Results and discussion
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Collagen is the ultimate load-bearing structure in the aneurysm wall, as illustrated two decades 
ago when vessels were treated with collagenase and elastase, respectively.(18) Collagenase-
treated vessel ruptured, whereas elastase-treated vessels merely dilated.(18)
The results of this study suggest that either there is no difference in collagen between men and 
women and thereby no relation to the gender differences observed in aneurysm progression, 
or there is a difference but this study failed to address it, by for instance not comparing the 
amount of collagen between the sexes.(95)  
The findings of a lower HP/LP ratio suggest a different collagen cross-linking in the aneurysm 
wall of men and women but it is difficult to value the difference without a plausible explanation 
as to how it might have come about. One plausible explanation to the lack of difference in the 
expression of the enzymes essential for collagen cross-linking is that few cells are involved 
in tissue repair in the end-stage of aneurysm disease. 
a)	  
c)	  
b)	  
a)	  
c)	  
b)	  
Figure VI. a) Masson trichome staining of 
thrombus coverd aneurysm wall in men and 
b) women. c) Relative collagen content in 
thrombus covered aneurysm wall of men and 
women, in Hyp/Pro ratio, P=.645. Hyp/Pro- 
hydroxyproline/proline.
Table	III. Gene expression analysis of collagen in the thrombus covered aneurysm wall of 
men and women.
Men with AAA
N=14
Women with AAA
N=14 P-value
collagen1α1 1.18 (1.10) 1.81 (.64) .094
collagen1α2 -1.14 ± .70 -.76 ± .90 .223
collagen3α1 .39 ± .87 .81 ± .94 .231
Values presented log2-transformed and as arbitrary units. Values are presented as median(IR) for 
not normally distributed data and mean±SD for normally distributed data. Significance calculated 
by Mann Whitney-U test and Independent t-test.
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In conclusion, the lack of difference in relative collagen content between the sexes together 
with a difference in collagen cross-linking between the sexes in the aneurysm wall, suggest 
that there might be biomechanical differences between the sexes. Further analyses are 
required to assess the role of gender on collagen biosynthesis and  its potential association to 
women’s higher rupture risk. 
Methodological considerations
The main limitation of study IV is the analysis of collagen content. As opposed to relative 
collagen content, collagen content was not analysed. The study would have benefited from 
the analysis.
★	  
★	   ★	  
a)	  
b)	  
c)	  
Figure VII. a) Cross-linking of collagen in thrombus covered aneurysm wall of men and women. 
HP per triple helix, P=.139, b) LP per triple helix, ★P=.005 and c) HP/LP ratio, ★★P=.003.
Results and discussion
42
Christina Villard
VSMCs, apoptosis and inflammatory cells in the aneurysm wall
The loss of vascular smooth muscle cells by apoptosis is an important element in the 
pathogenesis of AAA, but there is little knowledge of its extent in the aneurysm wall of 
women.(180) 
In Study V, we investigated the expressions of smooth muscle cell markers in the aneurysm 
wall of men and women and found a lower protein expression of smooth muscle α–actin in 
women, assessed with immunohistochemistry and western blot analysies. Figure VIII and 
Figure X. This difference could not be observed in mRNA expression analysis of smooth 
muscle α–actin. Table IV. There were no differences in the protein and mRNA expressions of 
myocardin and MYH11 between the sexes. Table IV. The mRNA expression of smoothelin 
was higher in women compared with men, yet no differences were observed in protein 
expression analyses.
The lower expression of smooth muscle α–actin in women compared with men suggest a 
lower amount of VSMCs in the aneurysm wall of women. A plausible explanation, to the 
lack of difference in mRNA expression analysis of most smooth muscle markers, might be 
that there are few cells in both men and women that express and synthesise the contractile 
proteins in the end-stage of aneurysm disease. 
This study is the first to evaluate the apoptotic process in the aneurysm wall with a gender 
Table IV. Gene expression analysis of markers of smooth muscle cells, apoptosis and 
inflammation in men and women with AAA
Men with AAA
n=21
Women with AAA
n=19 P-value
Markers of smooth muscle cells
smooth muscle α-actin -.73 (1.87) -.09 (2.33) .136
myocardin 7.67 (3.70) 8.51 (3.22) .581
MYH11a .13 ± 1.54 .88 ± 2.35 .267
smoothelin 4.63 (1.01) 5.41 (1.94) .045
Markers of apoptosis
caspase 3 5.53 (.58) 5.69 (.86) .970
p53b 4.47 (.60) 4.83 (.82) .045
BAXc 4.11 ± .51 4.55 ± .74 .045
Fasd 3.86 (.42) 3.89 (.92) .407
Markers of inflammation
CD247e 6.38 (1.14) 6.84 (1.49) .068
CD4 4.01 (1.06) 4.95 (1.19) .012
CD8 6.60 (1.32) 7.34 (1.96) .271
CD68 .63 (1.20) 1.67 (1.20) .011
MS4A1f 4.81 (3.87) 4.21 (3.69) .510
Values presented log2-transformed and as arbitrary units. Values are presented as mean ± SD for normally 
distributed data, and median (IR) for not normally distributed data. Significance calculated by independent 
t-test, and Mann Whitney-U test. aMYH11- myosin, heavy chain 11, smooth muscle. bp53- tumor protein 
p53. cBAX- BCL2-associated X protein. dFAS- Fas cell surface death receptor. eCD- cluster of differentiation 
fMS4A1- membrane-spanning 4 domains subfamily A member 1.
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perspective. The observed greater proportion of apoptotic cells in the medial layer of women 
compared with that in men, .92 vs. .66, P=.005, suggest a more pronounced apoptosis in the 
aneurysm wall of women compared with men. Figure VIII and Figure IX. In addition the 
expressions of p53 and BAX, both markers of apoptosis, were higher in women compared 
with men. Table IV and Figure X.
The more pronounced apoptosis in the aneurysm wall of women could be related to a more 
pronounced inflammation. In order to value the amount of inflammatory cells, we analysed 
the expression of inflammatory markers in men and women. We found a greater expression of 
CD68, marker for macrophages, and CD4, a marker for CD4+lymphocytes. Table IV, Figure 
VIII and Figure X. There was no significant difference in the mRNA expression of CD247, 
a marker of T-lymphocytes, CD8, a maker or CD8+lymphocytes and MS4A1, a marker or 
B-cells between the sexes. Table IV.
Figure VIII.  a) α–actin staining of the thrombus covered aneurysm wall of men and b) women. 
c) TUNEL staining of thrombus covered aneurysm wall of men and d) women. e) Staining of 
CD68 in men and f) women.
Results and discussion
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Figure IX. Proportion of apoptotic cells in the thrombus covered aneurysm wall of men and 
women, ★P=.005
Figure X. Western blot of α–actin in the thrombus covered aneurysm wall of 2 men and 3 
women. b) Western blot of p53 in the thrombus covered aneurysm wall of 2 men and 3 women. 
c) Western blot of CD68 in the thrombus covered aneurysm wall of 2 men and 3 women. 
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VSMC is the primary cell type of the aortic wall.(9) The role of VSMCs in aneurysm 
formation is dual, with the loss of VSMC by apoptosis the vessel wall loses its capacity to 
oppose degradation, but VSMCs have also been shown to promote aneurysm development by 
producing proteolytic enzymes.(48, 181) The observed lower expression of smooth muscle 
α–actin could suggest a lower amount of VSMCs in the aneurysm wall of women. This 
study was not designed to value phenotype modification in men and women with end-stage 
aneurysm disease and consequently no conclusions can be drawn from the results of mRNA 
expression analysis. 
The observed greater proportion of apoptotic cells in the aneurysm wall of men and women 
suggest that the aneurysm wall has a heightened sensitivity for apoptotic stimuli, which might 
be related to an amplification of the death-promoting pathway of p53 and BAX. 
The higher expressions of the inflammatory markers of macrophages and CD4+lymphocytes 
in the aneurysm wall of women could be explained by a more pronounced infiltration of these 
cells in the aneurysm wall of women. A more pronounced inflammation in the aneurysm wall 
of women could hypothetically affect the observed findings of apoptosis and smooth muscle 
cell markers. However, without analyses on how they potentially interact little can be said 
of their relation to one another. Thereto we found a difference in ASI between the sexes, to 
relate to the above mentioned findings. Women had a higher ASI compared with men, 3.4 vs. 
3.1, P=.013.  
In conclusion, a more pronounced apoptosis in the aneurysm wall of women, potentially 
related to an abundance of inflammatory cells, could be of importance for the gender 
differences in AAA development and progression.
Methodological considerations
The observations in Study V suggest an association between the amounts of infiltrating 
inflammatory cells, VSMCs and apoptosis but cannot provide information on how the 
association is mediated. Analysis of relevant cytokines might be a first step. Furthermore 
there are limitations to the TUNEL analysis. We cannot conclude that it is in fact apoptosis 
of VSMCs that we have observed even though it is likely so. Another limitation is the use 
smooth-muscle α-actin as a marker of VSMCs, since smooth-muscle α-actin is not exclusive 
for VSMCs but can also be expressed by for instance myofibroblasts.(182) Thereto it could 
be of value to perform western blot analysis on all the smooth muscle cell markers that was 
analysed by mRNA expression analysis. 
Results and discussion
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impLementAtions And  
future perspectives
The finding of a lower menopausal age in women with large AAA corresponds with a protective 
effect of female sex hormones on the development and growth of AAA.  Theoretically, 
women who develop AAA are fundamentally different from women in the population, with a 
vascular susceptibility to disease, possibly related to sex hormones. Together with a disease-
provoking event, such as for instance smoking, AAA formation might be triggered.
Considering hormone therapy to postpone menopause and thereby prevent aneurysm 
development in women is an appealing idea but could not be considered safe due to the 
adverse events observed in the WHI trails. The results of these trials illustrate the complex 
and opposing effects that sex hormones mediate on the vasculature in different stages of life.
It would be interesting to pursue the studying of a potential effect of gender on aneurysm 
development, which could have implications for both men and women. One way to further 
approach this area is to specifically study groups of patients with either premature artificial 
menopause or treatments including hormones and hormone antagonists and the potential 
effect of these therapies on the aortic wall and aortic diameter. Another way to deepen the 
understanding of the aneurysm wall and triggers for aneurysm development could be to 
study the aneurysm wall in relation to the aortic wall of healthy persons in different age 
groups. This wall analysis could then be linked to circulating hormone levels, giving better 
estimations of the influence of sex hormones on the aging aortic wall and what is altered in 
the aneurysm wall.
The observations from our study on biomarkers showed that even though men and women 
do not have identical biomarker profiles, they are in many aspects similar. The results do 
emphasize that future analysis should consider gender differences and efforts should be 
made to include women in reports on AAA. It seems particularly important to seek different 
biomarkers for different risk groups; it is probable that these are dependant on the “trigger” 
mechanisms for disease and progression. Maybe focus should be on identifying a biomarker 
able to single out patients with risk of growth and rupture, rather than a diagnostic marker, 
due to the present difficulty in estimating which patients are at risk for progression. 
AAA behaves differently in women, illustrated by the higher rupture rate in women compared 
with men. The findings of Study III-V suggest that the aneurysm wall differ in men and 
women. The observed differences in the structural elements and degenerative markers of 
the aneurysm wall in men and women imply that there is a more pronounced degradation 
in the aneurysm wall of women. It could have implications for the observed lower wall 
strength in the aneurysm wall of women. A greater relative enlargement in women cannot 
however, solely explain the suggested more pronounced degradation in the aneurysm wall 
of women. Instead there are also most likely essential differences in the vessel wall between 
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men and women and between women who develop AAA and those who do not. The potential 
differences in the composition of the aortic wall between men and women might become 
especially important as an AAA evolves, resulting in, as suggested, a weaker aneurysm wall 
in women.
A lower expression of elastin and higher expression of MMP-9 in the aneurysm wall of 
women could have implications for aneurysm enlargement. It would be interesting to study 
women and men without disease to value if there are any inherent gender differences in the 
elastin content to associate with our findings. 
It is appealing to study collagen and its cross-linking with a gender perspective, based on the 
load-bearing qualities of collagen and women’s higher rupture risk. However, the results from 
our study are inconclusive regarding a potential effect of gender on collagen biosynthesis.
Further analyses are required in order to reach a more accurate conclusion of the role of 
collagen in relation to women’s higher rupture risk. 
In order to value the observed differences in apoptosis, VSMC content and inflammatory 
cells in the aneurysm wall of men and women, further analyses are required. It would be 
of interest to study potential mechanisms through which the greater proportion of apoptotic 
cells, higher expression of inflammatory cells and lower expression of smooth muscle α–
actin possibly relate to one another. It could potentially increase the understanding of AAA 
development in both men and women.
In conclusion, women with larger AAA have an altered reproductive history with a lower mean 
menopausal age, suggesting hormonal changes to be of importance for AAA development in 
women. The observed gender differences in the aortic wall described in the thesis, contributes 
to the presently poorly understood biological and morphological processes that triggers 
aneurysm development, progression and rupture. 
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